| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on May 2, 2005
Accepted on August 1, 2005
Laboratories of Cardiovascular Nutrition (N.E.S., P.J.N.) and *Human Neurotransmitters (E.A.L., G.W.L., K.M., M.D.E.), Baker Heart Research Institute, P.O. Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, AUSTRALIA
* To whom correspondence should be addressed. E-mail: Nora.Straznicky{at}baker.edu.au.
Context: Weight reduction, the first-line treatment for the metabolic syndrome (MetS), improves insulin sensitivity and associated metabolic and cardiovascular abnormalities but there is a paucity of data regarding its effect on sympathetic nervous system (SNS) activity in this clinical setting.
Objectives: 1. To test the hypothesis that dietary weight loss attenuates both insulin resistance and SNS activity. 2. To examine the relationships between SNS activity and MetS components.
Design: Single-sample, repeated-measures design
Setting: Tertiary referral center
Participants: Twenty-three MetS subjects (age, 58 ± 2 yr; body mass index 33.3 ± 0.8 kg/m2, mean ± SEM).
Intervention: Hypocaloric modified DASH diet (26% fat, 22% protein, 51% carbohydrate, 100 mmol/day sodium) consumed for 3 months.
Main Outcome Measures: Postganglionic muscle sympathetic nerve activity (MSNA, microneurography at a peroneal nerve), whole-body plasma norepinephrine spillover rate, spontaneous cardiac baroreflex function and insulin sensitivity.
Results: The hypocaloric diet significantly reduced body weight by 7% and improved all MetS components. Norepinephrine spillover decreased from 877 ± 180 to 503 ± 39 ng/min (P = 0.005) and MSNA from 40.6 ± 2.1 to 34.6 ± 2.4 bursts per minute (P = 0.01), while cardiac baroreflex sensitivity increased by 23.0 ± 8.0% (P = 0.02). Change in norepinephrine spillover rate correlated positively and independently with change in plasma leptin concentration (r= 0.49, P = 0.03).
Conclusion: Weight loss by a hypocaloric diet with moderate sodium restriction diminishes SNS activity in MetS subjects. This may be due to the consequences of decreased leptin concentration, enhanced insulin sensitivity or improvements in cardiac baroreflex function.
This article has been cited by other articles:
![]() |
N. E Straznicky, G. W Lambert, K. Masuo, T. Dawood, N. Eikelis, P. J Nestel, M. T McGrane, J. A Mariani, F. Socratous, R. Chopra, et al. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome Am. J. Clinical Nutrition, January 1, 2009; 89(1): 27 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Ramos and K. Olden The Prevalence of Metabolic Syndrome Among US Women of Childbearing Age Am J Public Health, June 1, 2008; 98(6): 1122 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Pricher, K. L. Freeman, and V. L. Brooks Insulin in the Brain Increases Gain of Baroreflex Control of Heart Rate and Lumbar Sympathetic Nerve Activity Hypertension, February 1, 2008; 51(2): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Gentile, J. S. Orr, B. M. Davy, and K. P. Davy Modest weight gain is associated with sympathetic neural activation in nonobese humans Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1834 - R1838. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Heusser, S. Engeli, J. Tank, A. Diedrich, S. Wiesner, J. Janke, F. C. Luft, and J. Jordan Sympathetic Vasomotor Tone Determines Blood Pressure Response to Long-Term Sibutramine Treatment J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1560 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Grassi, G. Seravalle, F. Quarti-Trevano, F. Scopelliti, R. Dell'Oro, G. Bolla, and G. Mancia Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome: Characteristics and Mechanisms Hypertension, March 1, 2007; 49(3): 535 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Esler, N. Straznicky, N. Eikelis, K. Masuo, G. Lambert, and E. Lambert Mechanisms of Sympathetic Activation in Obesity-Related Hypertension Hypertension, November 1, 2006; 48(5): 787 - 796. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |